Hoerter Steven L.
President and CEO at Deciphera Pharmaceuticals, Inc.; Chief Commercial Officer at AGIO; Officer at Clovis Oncology, Inc.
- Sold, on record
- $9.4M
- Dollars the filings state
- Form 4 sales
- 18
- Latest Dec 13, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- Deciphera Pharmaceuticals, Inc.President and CEO
- AGIOAGIOS PHARMACEUTICALS, INC.Chief Commercial Officer
- Clovis Oncology, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Deciphera Pharmaceuticals, Inc.89,782 shares
- Clovis Oncology, Inc.60,000 shares
- AGIO49,350 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale AGIOUnusualJun 22, 2018 2018
Sold 2,050 shares at $97.58 ($200k)
Hoerter Steven L., Chief Commercial Officer
Sold 100% of holdings ($200k position)0 shares left1x usual sizeFiling
- 2 Form 4 sale AGIOUnusualJul 25, 2018 +33 days
Sold 2,050 shares at $84.58 ($173k)
Hoerter Steven L., Chief Commercial Officer
Sold 100% of holdings ($173k position)0 shares left1x usual sizeFiling
- 3 Form 4 sale AGIOUnusualAug 24, 2018 +30 days
Sold 2,050 shares at $74.92 ($154k)
Hoerter Steven L., Chief Commercial Officer
Sold 100% of holdings ($154k position)0 shares left1x usual sizeFiling
- 4 Form 4 sale AGIOUnusualMar 4, 2019 +192 days
Sold 10,000 shares at $67.01 ($670k)
Hoerter Steven L., Chief Commercial Officer
Sold 47.8% of holdings ($1.4M position)10,941 shares left4.9x usual sizeFiling
- 5 Form 4 sale Deciphera Pharmaceuticals, Inc.UnusualFeb 14, 2023 +1443 days
Sold 30,045 shares at $16.00 ($481k)
Hoerter Steven L., President and CEO
Sold 80% of holdings ($601k position)7,500 shares leftFirst sale on recordFiling
- 6 Form 4 sale Deciphera Pharmaceuticals, Inc.UnusualMar 21, 2023 +35 days
Sold 7,500 shares at $15.57 ($117k)
Hoerter Steven L., President and CEO
No 10b5-1 planSold 100% of holdings ($117k position)0 shares leftFiling
- 7 Form 4 sale Deciphera Pharmaceuticals, Inc.UnusualOct 30, 2023 +223 days
Sold 21,573 shares at $12.02 ($259k)
Hoerter Steven L., President and CEO
No 10b5-1 planSold 34.5% of holdings ($751k position)40,927 shares leftFiling
- 8 Form 4 sale Deciphera Pharmaceuticals, Inc.UnusualDec 13, 2023 +44 days
Sold 30,664 shares at $15.37 ($471k)
Hoerter Steven L., President and CEO
No 10b5-1 planSold 29.6% of holdings ($1.6M position)72,763 shares left1.4x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (18)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2023 | Dec 14, 2023 | Deciphera Pharmaceuticals, Inc. | President and CEO | Form 4 sale | 30,664 | $471k | 29.6% | Unusual | SEC |
| Oct 30, 2023 | Oct 31, 2023 | Deciphera Pharmaceuticals, Inc. | President and CEO | Form 4 sale | 21,573 | $259k | 34.5% | Unusual | SEC |
| Mar 21, 2023 | Mar 23, 2023 | Deciphera Pharmaceuticals, Inc. | President and CEO | Form 4 sale | 7,500 | $117k | 100.0% | Unusual | SEC |
| Feb 14, 2023 | Feb 16, 2023 | Deciphera Pharmaceuticals, Inc. | President and CEO | Form 4 sale | 30,045 | $481k | 80.0% | Unusual | SEC |
| Mar 4, 2019 | Mar 5, 2019 | AGIO | Chief Commercial Officer | Form 4 sale | 10,000 | $670k | 47.8% | Unusual | SEC |
| Aug 24, 2018 | Aug 28, 2018 | AGIO | Chief Commercial Officer | Form 4 sale | 2,050 | $154k | 100.0% | Unusual | SEC |
| Jul 25, 2018 | Jul 27, 2018 | AGIO | Chief Commercial Officer | Form 4 sale | 2,050 | $173k | 100.0% | Unusual | SEC |
| Jun 22, 2018 | Jun 26, 2018 | AGIO | Chief Commercial Officer | Form 4 sale | 2,050 | $200k | 100.0% | Unusual | SEC |
| May 23, 2018 | May 29, 2018 | AGIO | Chief Commercial Officer | Form 4 sale | 2,050 | $176k | 100.0% | Unusual | SEC |
| Apr 23, 2018 | Apr 25, 2018 | AGIO | Chief Commercial Officer | Form 4 sale | 2,050 | $176k | 100.0% | Unusual | SEC |
| Mar 22, 2018 | Mar 26, 2018 | AGIO | Chief Commercial Officer | Form 4 sale | 2,050 | $174k | 100.0% | Unusual | SEC |
| Feb 22, 2018 | Feb 26, 2018 | AGIO | Chief Commercial Officer | Form 4 sale | 2,050 | $161k | 100.0% | Unusual | SEC |
| Jan 23, 2018 | Jan 25, 2018 | AGIO | Chief Commercial Officer | Form 4 sale | 25,000 | $1.9M | 100.0% | Unusual | SEC |
| Mar 5, 2015 | Mar 9, 2015 | Clovis Oncology, Inc. | Officer | Form 4 sale | 20,000 | $1.6M | 100.0% | Unusual | SEC |
| Feb 17, 2015 | Feb 19, 2015 | Clovis Oncology, Inc. | Officer | Form 4 sale | 10,000 | $720k | 100.0% | Unusual | SEC |
| Jan 16, 2015 | Jan 20, 2015 | Clovis Oncology, Inc. | Officer | Form 4 sale | 10,000 | $670k | 100.0% | Unusual | SEC |
| Jan 13, 2015 | Jan 15, 2015 | Clovis Oncology, Inc. | Officer | Form 4 sale | 10,000 | $620k | 100.0% | Unusual | SEC |
| Jun 4, 2013 | Jun 6, 2013 | Clovis Oncology, Inc. | Officer | Form 4 sale | 10,000 | $731k | 100.0% | Unusual | SEC |